Thozama Dubula

Nelson Mandela Academic Clinical Research Unit (NeMACRU)

Mthatha, EC

Clinical Trials:Currently Recruiting for 2 Trials

About|Expertise|Location|Research

Areas of Expertise

Many experts have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a expert treats and their level of experience.

Experienced

Check Thozama Dubula's experience treating your condition:

About Thozama Dubula

Thozama Dubula practices in Mthatha, South Africa. Their top areas of expertise are Systemic Lupus Erythematosus (SLE), HIV/AIDS, Middle East Respiratory Syndrome (MERS), and Pneumonia.

Their clinical research consists of co-authoring 10 peer reviewed articles and participating in 2 clinical trials in the past 15 years.

Locations

Mthatha, EC 5100, ZA

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

This is a Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety, and Tolerability of Molnupiravir 800 mg Administered 12-hourly for Five Days to Adult Patients With Mild COVID-19 at the Time of Enrolment Who Are at Risk of Progression to Severe Disease, Compared to a Placebo. Patients With Recent Onset of COVID-19 Symptoms Will be Screened to Assess Eligibility for Enrolment. Confirmation of SARS-CoV-2 Infection Will be Performed Through Rapid Antigen Detection Using the LumiraDx Point of Care Diagnostic Platform.

Enrollment Status: Recruiting

Publish Date: August 16, 2022

Intervention Type: Drug

Study Phase: Phase 3

Open-label, Single-arm Phase 3B Implementation Study to Evaluate the Effectiveness of the Homologous Boostof Ad26.COV2.S COVID-19 Vaccine Following the Prime Dose Among Sisonke Participants in South Africa(VAC31518COV30XX)

Enrollment Status: Recruiting

Publish Date: August 01, 2022

Intervention Type: Biological

Study Phase: Phase 3

10 Total Publications